Grail, Inc. (NASDAQ:GRAL - Get Free Report) shares rose 5.4% during trading on Wednesday . The company traded as high as $35.10 and last traded at $34.94. Approximately 238,647 shares traded hands during trading, a decline of 77% from the average daily volume of 1,049,903 shares. The stock had previously closed at $33.15.
Analyst Ratings Changes
GRAL has been the topic of a number of research analyst reports. Morgan Stanley initiated coverage on shares of Grail in a research report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price objective on the stock. Wolfe Research initiated coverage on shares of Grail in a research report on Friday, November 15th. They issued a "peer perform" rating for the company.
View Our Latest Stock Analysis on GRAL
Grail Trading Up 1.0 %
The business's 50-day moving average is $23.94 and its 200-day moving average is $18.13.
Institutional Investors Weigh In On Grail
A number of hedge funds have recently added to or reduced their stakes in the stock. FNY Investment Advisers LLC bought a new position in shares of Grail in the 4th quarter valued at about $26,000. Lindbrook Capital LLC acquired a new stake in Grail during the 4th quarter worth approximately $28,000. State of Tennessee Department of Treasury acquired a new stake in shares of Grail in the fourth quarter valued at approximately $28,000. Sterling Capital Management LLC acquired a new stake in shares of Grail in the fourth quarter valued at approximately $29,000. Finally, Wellington Shields Capital Management LLC bought a new position in shares of Grail in the fourth quarter valued at $33,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
